Hillsdale Investment Management Inc. Biogen Inc. Transaction History

Hillsdale Investment Management Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$187.54 - $223.02 $18,754 - $22,302	100 Added 5.92%	1,790 $365,000
Q3 2021 Oct 21, 2021	BUY	$282.99 - $369.05 $11,319 - $14,762	40 Added 2.42%	1,690 $478,000
Q2 2021 Jul 29, 2021	BUY	$259.0 - $414.71 $427,350 - $684,271	1,650 New	1,650 $571,000
Q1 2021 Apr 22, 2021	SELL	$242.95 - $284.63 $442,897 - $518,880	-1,823 Closed	0 $0
Q2 2020 Aug 11, 2020	BUY	$258.66 - $342.55 $12,933 - $17,127	50 Added 2.82%	1,823 $487,000
Q1 2020 May 12, 2020	SELL	$268.85 - $341.04 $3,226 - $4,092	-12 Reduced 0.67%	1,773 $561,000
Q4 2019 Feb 12, 2020	BUY	$220.06 - $304.07 $11,003 - $15,203	50 Added 2.88%	1,785 $529,000
Q3 2019 Nov 13, 2019	BUY	$217.44 - $243.88 $4,348 - $4,877	20 Added 1.17%	1,735 $404,000
Q2 2019 Aug 02, 2019	BUY	$219.29 - $241.72 $65,787 - $72,516	300 Added 21.2%	1,715 $402,000
Q2 2018 Aug 13, 2018	SELL	$257.52 - $306.91 $1,287 - $1,534	-5 Reduced 0.35%	1,415 $410,000
Q3 2017 Nov 13, 2017	BUY	$281.15 - $329.69 $56,229 - $65,938	200 Added 16.39%	1,420 $445,000
Q2 2017 Aug 14, 2017	BUY	N/A	1,220	1,220 $330,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Hillsdale Investment Management Inc., based on Form 13F filings with the SEC.

Stay updated on Hillsdale Investment Management Inc. with notifications on news.